HOME
ABOUT OPDC
PRESS ROOM
THERAPEUTIC CATEGORIES
CAREERS
OAPI
OMML
Contact us
|
Search Site
|
Site Map
Press Releases
Archives
Public Relations Contacts
Press Kit
Font Size:
OPDC
Press Releases
September 4, 2008
September 4, 2008: Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for ACU-4429 in Dry Age Related Macular Degeneration
September 4, 2008
September 4, 2008: Acucela and Otsuka Pharmaceutical Enter Co-Development Agreement for Rebamipide Ophthalmic Suspension for Dry Eye
August 26, 2008
Otsuka Pharmaceutical Co., Ltd. Makes Capital Investment to Acquire Interpharma Praha, Czech Republic
June 25, 2008
U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia
* OAPI, OPDC and OMML are subsidiaries of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd.
